ARIS
IBB icon

Advanced Research Investment Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Advanced Research Investment Solutions’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25
Closed -$3K – 152
2022
Q1 		$3K Buy
+25
New +$3.26K ﹤0.01% 178

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Advanced Research Investment Solutions's IBB Position: Q2 2022 in Review

Advanced Research Investment Solutions sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 25 shares — an estimated $3K sold.

Advanced Research Investment Solutions first reported a position in IBB in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • Advanced Research Investment Solutions reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Advanced Research Investment Solutions sold 25 iShares Biotechnology ETF shares in Q2 2022, an estimated $3K.
  • Advanced Research Investment Solutions first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 1 quarter.
  • Advanced Research Investment Solutions's iShares Biotechnology ETF position peaked at $3K in Q1 2022.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Advanced Research Investment Solutions's 13F filing for Q2 2022, filed 3 Aug 2022.